Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!
Momenta
Home  »  Community News  »  Momenta
Jun
22
sandeepsd
Sandoz launches Glatopa in US market to treat multiple sclerosis
Pharma News
0
, , , , , , , ,

Sandoz, a Novartis company, has launched Glatopa in US markets. Glatopa is the first generic version of Teva’s Copaxone (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy. Read more …